Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Aspirin Use on the Severity of Organ Dysfunctions in Patients With Sepsis and Septic Shock: a Randomized, Double-blind, Placebo-controlled Trial - ASP-SEPSIS.

NCT01784159 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT01784159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01784159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Aspirin Use on the Severity of Organ Dysfunctions in Patients With Sepsis and Septic Shock: a Randomized, Double-blind, Placebo-controlled Trial - ASP-SEPSIS.
Lead sponsor
Federal University of São Paulo
Phase
Phase 2
Overall status
Terminated
Start date
March 27, 2019
Completion date
January 5, 2023
Enrollment
167 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis